Graves_病诊疗新进展_第1页
Graves_病诊疗新进展_第2页
Graves_病诊疗新进展_第3页
Graves_病诊疗新进展_第4页
Graves_病诊疗新进展_第5页
已阅读5页,还剩77页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、1会计学Graves_病诊疗新进展病诊疗新进展牛牛文库文档分享牛牛文库文档分享50/100,000 = 0.5/1000 = 1 out of every 2000 people everyyear牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享Antithyroid DrugsNonablativeLowfrequencyNot definitive, side-effects+RadioiodineDefinitive100%fear+SurgeryDefinitive100%complications, discomfort+Advanta

2、gesHypothyroidismOther DisadvantagesCost牛牛文库文档分享Glinoer et a.l 1987, Solomon et al. 1990, Walsh 2000, Tominaga et al.1997牛牛文库文档分享Tominaga et al. 1997牛牛文库文档分享Tominaga et al. 1997牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享NCNSOCH2CH2CH36-propyl, 2-thiouracil (PTU)CHNCNHS1 methyl, 2 mercaptoimidazole (MMI)-OCH2CH3 (CBZ)l

3、lO牛牛文库文档分享12Cooper DS NEJM 2005牛牛文库文档分享抗甲状腺药物不良反应:甲状腺之外甲状腺之外Thyroxine (T4)(T4)(T3)Cooper DS NEJM 2005BUT: This does nottranslate into PTUbeing a “better” drugfor sicker pateints牛牛文库文档分享牛牛文库文档分享需要讨论的问题牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享Nakamura et al. JCEM 2007Group B FT4 7 ng/dl牛牛文库文档分享010203040506070T4 21, CB

4、Z20T4 21, CBZ40T4 21, CBZ20T4 21, CBZ20T4 21, CBZ40T4 21, CBZ20T4 2x ULN)Skin RashDecr. WBC (1000)PTU 30051.9%*26.9%*22.1%4.8%*MMI 1513.9%*9%6.6%*0.7%MMI 3030%6.6%22.3%0%牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享 总结:选择哪种药物好?总结:选择哪种药物好?牛牛文库文档分享总结:选择哪种药物好?总结:选择哪种药物好?牛牛文库文档分享牛牛文库文档分享010203040506070Allannic1990Garcia1995

5、Weetman1994Maugendre1998% relapse*61812246121842牛牛文库文档分享3.8ng/dl 8Group A Group BGroup C牛牛文库文档分享需要讨论的问题需要讨论的问题:牛牛文库文档分享FactorChance of remissionATD as first line therapyLarge GoiterLowerNoSeverely abn. TFTs ( T3)LowerNoPrior relapsesLowerNoNeg TSIHigherYesSmoking?no effect-Eye Disease? no effect-Age

6、no effect-牛牛文库文档分享FactorChance of remissionATD as first line therapyLarge GoiterLowerNoSeverely abn. TFTs ( T3)LowerNoPrior relapsesLowerNoNeg TSIHigherYesSmoking?no effect-Eye Diseaseno effect-Ageno effect-牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享6.3 mCi9.4 mCi8.5 mCi12.3 mCiPercent牛牛文库文档分享 注意注意:牛牛文库文档分享牛牛文

7、库文档分享牛牛文库文档分享10/229/1945%47%Worse Pre-existing GOWorse New onset GO38%18%53/14123/131P700 ng/dl, very large goiter (4 times normal)Mild or moderate hyperthyroidism, small or modestly enlarged thyroid; Children or pregnant/lactating women; patients with severe eye diseaseDefinitive therapy with radio

8、iodine preferred in adultsNormalization of thyroid function with antithyroid drugs before therapy in the elderly or patients with heart diseasePrimary antithyroid drug therapy should beconsideredstart methimazole 5-30 mg/day after discussing side-effects and obtaining CBC and differential. PTU only

9、used in pregnancyMonitor thyroid functionevery 4-6 weeks until euthyroid state achievedDiscontinue drug therapy after 12-18 monthsMonitor thyroid function every 2 months for 6 months, then less frequentlyRelapseRemissionmonitor thyroid function every 6-12 months indefinitelyConsider restarting antit

10、hyroid drugs after therapyCooper 2005牛牛文库文档分享牛牛文库文档分享牛牛文库文档分享22 patients16 treated with embolization alone; 6 required surgery/ATDNo serious complicationsJ Clin Endocrinol Metab. 2002 Aug;87(8):3583-9 牛牛文库文档分享“然而,由于方法学的限制,我们尚无设计良好的临床试验为中药治疗甲亢提供较强的证据。因此,我们现在不能推荐任何中药的单方或复方制剂在临床使用。”牛牛文库文档分享20 patients1

11、0 received MMI + rituximab (RTX), 10 MMI onlyHigher remission rates after MMI withdrawal with RTX (P700 ng/dl, very large goiter (4 times normal)Mild or moderate hyperthyroidism, small or modestly enlarged thyroid; Children or pregnant/lactating women; patients with severe eye diseaseDefinitive ther

12、apy with radioiodine preferred in adultsNormalization of thyroid function with antithyroid drugs before therapy in the elderly or patients with heart diseasePrimary antithyroid drug therapy should beconsideredstart methimazole 5-30 mg/day after discussing side-effects and obtaining CBC and differential. PTU only used in pregnancyMonitor thyroid functionevery 4-6 weeks until euthyroid state achievedDiscontinue drug therapy after 12-18 monthsMonitor thyroid fu

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

最新文档

评论

0/150

提交评论